Article info
Original research
Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres
- Correspondence to Professor Mario Mandalà, University of Perugia School of Medicine and Surgery, Perugia 06126, Italy; mario.mandala{at}unipg.it
Citation
Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres
Publication history
- Received March 4, 2021
- Revised March 23, 2021
- Accepted March 24, 2021
- First published April 7, 2021.
Online issue publication
July 19, 2022
Article Versions
- Previous version (7 April 2021).
- Previous version (4 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.